Aurobindo Pharma Limited (AUROPHARMA) — Capital Reinvestment Ratio
Aurobindo Pharma Limited (AUROPHARMA) has a Capital Reinvestment Ratio of 0.47x as of September 2025, meaning it reinvests 0% of its operating cash flow (Rs28.85 Billion) in capital expenditures (Rs13.63 Billion). Check how tangible is Aurobindo Pharma Limited's equity to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Aurobindo Pharma Limited Capital Reinvestment Ratio (2004–2026)
This chart tracks Aurobindo Pharma Limited's Capital Reinvestment Ratio across 22 annual periods. For the full cash flow conversion analysis, see Aurobindo Pharma Limited cash flow conversion.
Annual Capital Reinvestment Ratio for Aurobindo Pharma Limited (2004–2026)
Year-by-year Capital Reinvestment Ratio for Aurobindo Pharma Limited from 2004 to 2026. See AUROPHARMA FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2026 | 0.49x | Rs55.13 Billion | Rs26.86 Billion | ▼ -2.8% |
| 2025 | 0.50x | Rs39.25 Billion | Rs19.68 Billion | ▼ -65.7% |
| 2024 | 1.46x | Rs24.35 Billion | Rs35.62 Billion | ▲ +28.3% |
| 2023 | 1.14x | Rs23.87 Billion | Rs27.20 Billion | ▲ +111.4% |
| 2022 | 0.54x | Rs50.16 Billion | Rs27.05 Billion | ▼ -4.2% |
| 2021 | 0.56x | Rs33.29 Billion | Rs18.74 Billion | ▲ +72.3% |
| 2020 | 0.33x | Rs43.81 Billion | Rs14.31 Billion | ▼ -65.4% |
| 2019 | 0.94x | Rs16.51 Billion | Rs15.59 Billion | ▲ +20.6% |
| 2018 | 0.78x | Rs19.55 Billion | Rs15.30 Billion | ▲ +51.5% |
| 2017 | 0.52x | Rs32.79 Billion | Rs16.94 Billion | ▼ -53.1% |
| 2016 | 1.10x | Rs14.20 Billion | Rs15.66 Billion | ▲ +77.5% |
| 2015 | 0.62x | Rs12.37 Billion | Rs7.68 Billion | ▲ +2.8% |
| 2014 | 0.60x | Rs6.46 Billion | Rs3.90 Billion | ▼ -39.2% |
| 2013 | 0.99x | Rs2.75 Billion | Rs2.73 Billion | ▼ -43.2% |
| 2012 | 1.75x | Rs3.26 Billion | Rs5.71 Billion | ▼ -18.0% |
| 2011 | 2.14x | Rs3.35 Billion | Rs7.16 Billion | ▲ +118.1% |
| 2010 | 0.98x | Rs4.29 Billion | Rs4.20 Billion | ▼ -72.4% |
| 2009 | 3.55x | Rs1.36 Billion | Rs4.83 Billion | ▲ +128.8% |
| 2008 | 1.55x | Rs1.59 Billion | Rs2.46 Billion | ▼ -91.3% |
| 2007 | 17.79x | Rs186.50 Million | Rs3.32 Billion | ▲ +560.9% |
| 2005 | 2.69x | Rs1.22 Billion | Rs3.29 Billion | ▼ -73.3% |
| 2004 | 10.08x | Rs198.90 Million | Rs2.00 Billion | — |